XML 35 R21.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Feb. 03, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-based Compensation Expense
The compensation cost for these plans was as follows (in thousands):
 
Fiscal Year Ended
 
 
February 3, 2018
 
January 28, 2017
 
January 30, 2016
 
 
(53 weeks)
 
(52 weeks)
 
(52 weeks)
 
Stock-based compensation expense by type:
      
  Stock options
 
$
224
  
$
384
  
$
391
 
  Restricted stock units
  
3,536
   
4,010
   
4,632
 
  Employee stock purchases
  
96
   
104
   
105
 
  Director deferred compensation
  
24
   
94
   
70
 
    Total stock-based compensation expense
  
3,880
   
4,592
   
5,198
 
  Income tax benefit recognized
  
1,363
   
1,655
   
1,895
 
     Stock-based compensation expense, net of income tax
 
$
2,517
  
$
2,937
  
$
3,303
 
Employee Stock Purchases during the period
Our employee purchases of common stock and the average price per share through the ESPP were as follows:
 
Fiscal Year Ended
 
Shares
Purchased
  
Average
Price Per
Share
 
February 3, 2018
  
23,555
  
$
16.36
 
January 28, 2017
  
14,890
  
$
28.48
 
January 30, 2016
  
12,251
  
$
33.40
 
Restricted Stock Unit Awards Activity
The following table summarizes the restricted stock unit awards activity under all of our plans during Fiscal 2018:

 
 
RSUs
  
PSUs
  
Totals
 
 
 
Number of
Awards
  
Weighted
Average
Grant-Date
Fair Value
  
Number of
Awards
  
Weighted
Average
Grant-Date
Fair Value
  
Number of
Awards
  
Weighted
Average
Grant-Date
Fair Value
 
Restricted stock unit awards outstanding at January 28, 2017
  
299,368
  
$
46.68
   
95,475
  
$
44.71
   
394,843
  
$
46.20
 
   Granted
  
111,790
   
29.75
   
54,900
   
29.30
   
166,690
   
29.60
 
   PSU adjustment (1)
  
-
   
-
   
(9,380
)
  
45.30
   
(9,380
)
  
45.30
 
   Vested
  
(72,449
)
  
50.91
   
(8,625
)
  
54.73
   
(81,074
)
  
51.31
 
   Forfeited, cancelled or expired
  
(25,098
)
  
41.27
   
-
   
-
   
(25,098
)
  
41.27
 
Restricted stock unit awards outstanding at February 3, 2018
  
313,611
  
$
40.10
   
132,370
  
$
37.55
   
445,981
  
$
39.34
 
   
    (1) PSU adjustment represents the net RSUs awarded to our NEOs above and below their target grants resulting from the achievement of performance goals above or below the performance targets established at grant.  One goal was achieved at 50% and another goal was achieved at 80% for all performance equity awards released in Fiscal 2018; therefore, the adjustment was negative.
Stock Option Activity
Activity for our option plans during Fiscal 2018 was as follows:

 
 
Number of
Shares
  
Weighted
Average
Exercise
Price
  
Weighted
Average
Remaining
Contractual
Term
(Years)
  
Aggregate
Intrinsic
Value
($000's)
 
Options outstanding at January 28, 2017
  
263,604
  
$
37.47
   
5.11
  
$
963
 
   Granted
  
41,549
   
22.08
         
   Exercised
  
(13,763
)
  
20.44
         
   Forfeited, cancelled or expired
  
(3,240
)
  
26.89
         
Options outstanding at February 3, 2018
  
288,150
  
$
36.15
   
5.12
  
$
324
 
 
                
Exercisable at February 3, 2018
  
269,573
  
$
37.72
   
4.81
  
$
161
 
Employee Stock Purchase Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Fair value weighted average assumptions
The assumptions used in the option pricing model were as follows:

 
 
Fiscal Year Ended
 
 
 
February 3, 2018
  
January 28, 2017
  
January 30, 2016
 
Weighted average fair value at date of grant
 
 
$4.06
  
 
$6.98
  
 
$9.48
 
Expected life (years)
  
0.25
   
0.25
   
0.25
 
Expected volatility
  
30.2% - 36.2%
 
  
30.1% - 32.0%
 
  
32.0% - 36.2%
 
Risk-free interest rate
  
1.19% - 2.48%
 
  
0.37% - 0.68%
 
  
0.02% - 0.09%
 
Dividend yield
 
None
  
None
  
None
 
Stock Options [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Fair value weighted average assumptions
Following is the weighted average fair value of each option granted during Fiscal 2018.  The fair value was estimated on the date of grant using the Black-Scholes pricing model with the following weighted average assumptions for each period:

  
Quarter Ended
 
  
April 29, 2017
  
October 28, 2017
  
February 3, 2018
 
Grant date
 
Mar 14
  
Sep 16
  
Sep 30
  
Dec 31
 
Exercise price
 
 
$29.75
  
 
$13.85
  
 
$14.25
  
 
$20.40
 
Weighted average fair value at date of grant
 
 
$8.47
  
 
$4.20
  
 
$4.09
  
 
$6.37
 
Expected option life (years)
  
4.46
   
4.46
   
3.98
   
3.98
 
Expected volatility
  
30.24%
 
  
33.27%
 
  
33.38%
 
  
36.18%
 
Risk-free interest rate
  
1.99%
 
  
1.73%
 
  
1.76%
 
  
2.08%
 
Dividend yield
 
None
  
None
  
None
  
None